Format

Send to

Choose Destination
Lancet Diabetes Endocrinol. 2018 Jun;6(6):435-437. doi: 10.1016/S2213-8587(17)30314-5. Epub 2017 Oct 10.

SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection.

Author information

1
The Hatter Cardiovascular Institute, University College London, London WC1E 6HX, UK.
2
The Hatter Cardiovascular Institute, University College London, London WC1E 6HX, UK. Electronic address: d.yellon@ucl.ac.uk.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center